Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review

J Int Med Res. 2020 Oct;48(10):300060520942095. doi: 10.1177/0300060520942095.

Abstract

Renal cell carcinoma (RCC) associated with Xp11.2 translocation/transcription factor E3 (TFE3) gene fusion is a rare and independent subtype of RCC included in the classification of MiT (microphthalmia-associated transcriptional factor) family translocation RCC. Herein, we report an adult case of Xp11.2 translocation RCC, and review the relevant literature to improve our understanding of the pathogenesis, epidemiology, clinical manifestations, diagnosis, differential diagnosis, treatment, and other aspects of the disease.

Keywords: TFE3+; Xp11.2/TFE3 associated renal cell carcinoma; chromosomal rearrangement; fluorescence in situ hybridization; immunohistochemical staining; prognosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics
  • Carcinoma, Renal Cell* / diagnosis
  • Carcinoma, Renal Cell* / genetics
  • Chromosomes, Human, X / genetics
  • Gene Fusion
  • Humans
  • In Situ Hybridization, Fluorescence
  • Kidney Neoplasms* / diagnostic imaging
  • Kidney Neoplasms* / genetics
  • Translocation, Genetic

Substances

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors